Enzo Biochem (ENZ)'s Clinical Labs Introduces Diagnostic Test That Assists in Early Detection of Lung Cancer
11/13/2012 10:11:21 AM
NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) announced today that its Enzo Clinical Labs has introduced a new diagnostic test that assists in risk assessment and early detection of lung cancer. It is being made available to physicians in the New York metropolitan market as well as New Jersey and Eastern Pennsylvania, where Enzo is the only clinical laboratory making the test available within those areas.
comments powered by